The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Advanced imaging to assess longitudinal vascular changes in brain metastases treated with checkpoint inhibition.
 
Albert Eusik Kim
No Relationships to Disclose
 
Ken Chang
No Relationships to Disclose
 
Kyrre E. Emblem
Patents, Royalties, Other Intellectual Property - NordicNeuroLab AS
 
Jayashree Kalpathy-Cramer
No Relationships to Disclose
 
Eudocia Quant Lee
Honoraria - Medlink
Consulting or Advisory Role - Prime Oncology
Patents, Royalties, Other Intellectual Property - Royalties from Wolter Kluwer for Up to Date, Inc
 
Nancy U. Lin
Consulting or Advisory Role - AstraZeneca; California Institute for Regenerative Medicine (CIRM); Daiichi Sankyo; Denali Therapeutics; Prelude Therapeutics; Prelude Therapeutics; Puma Biotechnology; Seagen
Research Funding - Genentech; Merck; Pfizer; Seagen
Patents, Royalties, Other Intellectual Property - Royalties for chapter in Up-to-Date regarding management of breast cancer brain metastases; Royalties, Jones & Bartlett
 
Sara M. Tolaney
Consulting or Advisory Role - Abbvie; AstraZeneca; Athenex; Bristol-Myers Squibb; Celldex; Certara Inc; CytomX Therapeutics; Daiichi Sankyo; Eisai; G1 Therapeutics; Genentech; Immunomedics/Gilead; Kyowa Hakko Kirin; Lilly; Merck; Mersana; NanoString Technologies; Nektar; Novartis; Odonate Therapeutics; OncoPep; Paxman; Pfizer; Puma Biotechnology; Samsung Bioepis; Sanofi; Seagen; Silverback Therapeutics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Nektar (Inst); Novartis (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Sanofi (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celldex; Eisai; Genentech/Roche; Immunomedics; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Pfizer; Puma Biotechnology
 
Lakshmi Nayak
Consulting or Advisory Role - Ono Pharmaceutical
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Ugonma Nnenna Chukwueke
Stock and Other Ownership Interests - Abbvie (I); Danaher (I); Novartis (I)
 
Kevin S. Oh
No Relationships to Disclose
 
Helen Alice Shih
Honoraria - UpToDate
 
Michael White
No Relationships to Disclose
 
Don P. Lawrence
No Relationships to Disclose
 
Beverly Moy
Consulting or Advisory Role - MOTUS (I)
Research Funding - Puma Biotechnology (Inst)
 
Justine Vanessa Cohen
Consulting or Advisory Role - Bristol-Myers Squibb; Genzyme
 
Anita Giobbie-Hurder
No Relationships to Disclose
 
Daniel P. Cahill
Consulting or Advisory Role - Boston Pharmaceuticals; GlaxoSmithKline; Lilly
 
Ryan J. Sullivan
Consulting or Advisory Role - alkermes; Asana Biosciences; AstraZeneca; Bristol-Myers Squibb; Eisai; Iovance Biotherapeutics; Merck; Novartis; OncoSec; Pfizer; Replimune
Research Funding - Aeglea Biotherapeutics (Inst); Amgen (Inst); Asana Biosciences (Inst); BeiGene (Inst); BioMed Valley Discoveries (Inst); Compugen (Inst); Deciphera (Inst); Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); Neon Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); Rubius Therapeutics (Inst); Sanofi (Inst); Strategia (Inst); Strategia (Inst); Viralytics (Inst)
 
Priscilla Kaliopi Brastianos
Honoraria - Pfizer
Consulting or Advisory Role - Dantari Pharmaceuticals; ElevateBio; Pfizer; SK Life Sciences; Voyager Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst)
 
Elizabeth Robins Gerstner
Consulting or Advisory Role - Array BioPharma (I); MyoKardia (I)